-->

Esai and Biogen Leqembi manufacturer receive FDA approval for Alzheimer's drug

Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review.

     


from USATODAY - News Top Stories https://ift.tt/84vaWp3
via

Related Posts with Esai and Biogen Leqembi manufacturer receive FDA approval for Alzheimer's drug